Ratings by WestPark Capital
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/8/2026 | N/A | Akebia Therapeutics | AKBA | New Coverage | Buy (N/A) |
4.50 (N/A) |
0.97 (0.62) |
-36.08% | Details |
| 4/30/2026 | N/A | Talphera | TLPH | New Coverage | Buy (N/A) |
N/A (N/A) |
0.81 (1.07) |
32.1% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 98 more... | |||||||||
